Albert Wolthuis

KU Leuven, Universitair Ziekenhuis Leuven

Papers

6

Total Citations

130

H-Index

3

About

Dr. Albert Wolthuis is a leading colorectal surgeon whose research focuses on advancing minimally invasive techniques for rectal cancer and ulcerative colitis. His major contributions center on optimizing surgical outcomes through innovative approaches like transanal total mesorectal excision (TME) and ileal pouch-anal anastomosis (IPAA). His landmark 2017 study comparing transanal versus transabdominal proctectomy in ulcerative colitis (80 citations) established ta-IPAA as a viable alternative, while his 2025 IntAct trial (29 citations) demonstrated the potential of indocyanine green fluorescence angiography to reduce anastomotic leaks—a critical complication in rectal cancer surgery. Dr. Wolthuis also led a prospective European trial (2024, 15 citations) comparing laparotomy, laparoscopic, robotic, and transanal TME in high-risk patients, providing crucial evidence for technique selection. His work on ventral mesh rectopexy (2025) explores variations in pelvic floor surgery, and he has pioneered robotic single-port proctectomy for ulcerative colitis. With over 130 citations across his most-cited works, Dr. Wolthuis continues to shape evidence-based surgical practice, improving safety and recovery for patients with complex colorectal conditions.

Research Focus

Key Achievements

3
H-Index
6
Papers
130
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Transanal Versus Transabdominal Minimally Invasive (Completion) Proctectomy With Ileal Pouch-anal Anastomosis in Ulcerative Colitis
80 citations · 2017
📈 Most Prolific Year: 2025 (3 Papers)
🤝 Key Collaborators: 59
🏛 Institutions: KU Leuven, Universitair Ziekenhuis Leuven

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago